Trial intelligence / Profile preview

Paclitaxel With Cisplatin vs Fluoropyrimidine With a Platinum Agent for Neoadjuvant Therapy in Operable Esophageal Cancer

NCT01372202Phase 2Terminated

Sponsor
Sidney Kimmel Comprehensive Cancer Center
Start
Jun 2011
Primary completion
Jun 2014
Modality
Cytokines & Interferons, Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 2 trial of Paclitaxel Micelles for Injection in esophageal cancer, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Jun 2011; status: terminated.

02

Drugs

Paclitaxel Micelles for Injection
03

Conditions

esophageal cancer

Beyond the preview

Go deeper on NCT01372202.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01372202.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call